Investigation of Mnesic Capacities in Patients With a Disorder of Consciousness
MemoDoC
1 other identifier
interventional
175
1 country
2
Brief Summary
Following severe brain damage, some individuals lose partial or total awareness of themselves and their environment, falling into a coma that can evolve towards a Disorder of Consciousness (DoC). Accurately diagnosing the depth of consciousness alteration, and thus characterizing the patient's residual state of consciousness, is a real medical challenge, yet crucial for establishing a neurological prognosis, predicting cognitive outcome, and guiding medical decisions. Clinicians attempt to classify DoC patients into different global states (e.g. coma, Unresponsive Wakefulness Syndrome (UWS), Minimally Conscious State (MCS)) depending on their residual level of arousal and awareness. In recent years, the improvement of diagnostic tools and the use of a multimodal approach combining clinical, neurophysiological and neuroimaging examinations, have greatly refined this assessment and revealed the existence of possible discrepancies between clinical observation (e.g. poor consciousness state like UWS) and brain activity (richer, MCS+ type, or even conscious) so-called Cognitive-Motor Dissociation, making it essential to search for any 'hidden cognition' not revealed by the clinical behavioral examination. It is therefore essential to have tools that can not only probe consciousness level, but also provide a detailed profile of patients' residual cognitive abilities - such as language, attention or memory - which are essential dimmensions of conscious experience and shape waking cognitive life. This could crucially improve the neurological diagnostic and prognostic' accuracy of these disorders, as well as allowing to infer the eventual subjective experience of these patients. Indeed, The investigator still know very little about the possible conscious 'contents' involved in these states. What does the possible 'mental life' of DoC patients look like? A multidimensional exploration of their cognition is needed, requiring the development of innovative methods capable of probing cognitive functions in the absence of any communication with the patient. Thus, the general aim of this study lies in the development of tools for the cognitive exploration of DoC patients and their application at patients' bedside in the Intensive Care Unit (ICU). We're particularly interested in assessing memory capacities in these patients, as exploration of memory has immediate clinical implications, since memory encoding during DoC could impact patients' quality of life and be implicated in the occurrence of post-traumatic stress disorder (PTSD) in case of consciousness recovery. More specifically, the investigator want to tackle the following questions: Are patients suffering from a DoC able to form, consolidate and retrieve new memories (anterograde memory)? Are they able to recall memories from their 'past life' (retrograde memory)? Previous research suggests that some DoC patients retain the ability to reactivate old autobiographical memory traces, and to present automatic short-term sensory memory processes, or residual working memory. Nevertheless, DoC patients' memory abilities have been little studied to date, despite their clinical relevance. The investigator postulate that memory could be differentially preserved between different clinical states of DoC such as UWS and MCS. At the group level, we expect MCS patients to have better learning and memory retrieval abilities than UWS patients. The investigator therefore expect memory functions to be affected by brain lesions and, consequently, by consciousness alteration, although the invenvisage the preservation of unconscious memory processes (e.g. in non-declarative memory subtypes such as perceptual memory) in UWS patients. We hypothesize that the presence of robust markers of memory processes will vary, at the single-patient level, according to the types and stages of memory tested, informing the cognitive profile of the patient suffering from a DoC. By providing information on the potential presence of memory capacities that cannot be revealed by clinical examination, the physiological tools we are developing in this study will open a crucial window onto non-communicating patients' cognition. Defining DoC patients' memory profile could not only improve their care during and after the disorder (reflection on the quality of life in ICU; better understanding of cognitive and psychological symptoms occurring after a DoC (e.g. amnesia, PTSD); orientation of rehabilitation strategies), but also improve the diagnostic accuracy of these troubles if memory proves to be differentially preserved between different DoC states such as UWS and MCS. Ultimately, we aim to refine the neurological prognosis of these non-responsive patients, by predicting their cognitive outcome thanks to these innovative physiological tools. On a more fundamental level, this project questions the interplay of memory and consciousness, exploring which forms of memory do and do not require a conscious state.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2025
CompletedFirst Posted
Study publicly available on registry
May 6, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2030
April 13, 2026
April 1, 2026
4.9 years
April 28, 2025
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EEG-Electrodermal activity
Composite primary outcome measure: Presence of at least one of the following three predifined markers of memory processes: * EEG cognitive evoked potentials * Significant modulation of electrodermal activity * Evidence of recollection of an auditory memory probe delivered during the Disorder of Consciousness
during hospitalization and at a distance during a post-resuscitation follow-up consultation for the second semi-structured interview assessing the recovery of the musical memory probe, generally between 3 and 12 months
Study Arms (2)
Patients suffering or who have suffered from a Disorder of Consciousness
EXPERIMENTALConscious Patients treated in Intensive Care Unit
ACTIVE COMPARATORInterventions
(Neuro)-physiological paradigms based on EEG, ECG, electrodermal activity, and respiratory activity recordings, and auditory and olfactive stimuli, to assess memory processes without the need to communicate ('no report' approach) in patients suffering from a Disorder of Consciousness and conscious controls. Semi-structured interviews and neuropsychological assessments (scales) in patients who have recovered from a Disorder of Consciousness and conscious controls to explore memories and subjective experience of the ICU
Eligibility Criteria
You may qualify if:
- Patients suffering from a Disorder of Consciousness:
- Patient not conscious according to the CRS-R scale (Kalmar \& Giacino, 2005)
- Age over 15 years and 3 months
- Free and informed consent signed by a third party (parental authority, trusted support person)
- Conscious patients (controls) :
- Age over 15 years and 3 months
- Cared for in an Intensive Care Unit
- Free and informed consent signature
- Patients who have regained consciousness after having suffered from a Disorder of Consciousness (if not included during their disorder):
- Age over 15 years and 3 months
- Free and informed consent signature if able, otherwise signature of relative (holders of parental authority for minors)
You may not qualify if:
- Previous severe neurodegenerative disease (e.g. Alzheimer's disease, Lewy body dementia)
- Deafness
- Patients under guardianship or trusteeship
- Pregnant and breast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
APHP, Pitié-Salpêtrière Hospital, Department of Anesthesia and Intensive Care, NeuroSurgery ICU
Paris, 75013, France
APHP, Pitié-Salpêtrière Hospital, Department of Neurology, Neuro-ICU
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Rohaut, MD PhD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2025
First Posted
May 6, 2025
Study Start
September 30, 2025
Primary Completion (Estimated)
August 30, 2030
Study Completion (Estimated)
August 30, 2030
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share